Lexaria Bioscience (LEXX) EBIAT (2017 - 2025)
Historic EBIAT for Lexaria Bioscience (LEXX) over the last 12 years, with Q4 2025 value amounting to -$1.6 million.
- Lexaria Bioscience's EBIAT rose 4097.81% to -$1.6 million in Q4 2025 from the same period last year, while for Nov 2025 it was -$10.8 million, marking a year-over-year decrease of 4736.63%. This contributed to the annual value of -$11.9 million for FY2025, which is 10506.36% down from last year.
- According to the latest figures from Q4 2025, Lexaria Bioscience's EBIAT is -$1.6 million, which was up 4097.81% from -$2.7 million recorded in Q3 2025.
- In the past 5 years, Lexaria Bioscience's EBIAT registered a high of -$652733.0 during Q1 2024, and its lowest value of -$3.8 million during Q2 2025.
- Over the past 5 years, Lexaria Bioscience's median EBIAT value was -$1.8 million (recorded in 2024), while the average stood at -$2.0 million.
- As far as peak fluctuations go, Lexaria Bioscience's EBIAT surged by 5019.73% in 2024, and later tumbled by 31624.55% in 2025.
- Quarter analysis of 5 years shows Lexaria Bioscience's EBIAT stood at -$2.0 million in 2021, then grew by 11.69% to -$1.8 million in 2022, then soared by 33.02% to -$1.2 million in 2023, then crashed by 128.4% to -$2.7 million in 2024, then skyrocketed by 40.98% to -$1.6 million in 2025.
- Its last three reported values are -$1.6 million in Q4 2025, -$2.7 million for Q3 2025, and -$3.8 million during Q2 2025.